Decision on CF drug will fall to next government

Susan Mitchell

Deputy Editor and Health Editor @susmitchellsbp
27th March, 2016
Philip Watt, chief executive of the Cystic Fibrosis Association of Ireland Pic:

Vertex Pharmaceuticals has made a submission to the state’s cost-effectiveness watchdog for the approval of its cystic fibrosis drug Orkambi.

The National Centre for Pharmacoeconomics (NCPE) is due to make a recommendation on whether the state should fund the new drug before the end of June. Cystic Fibrosis Ireland has described Orkambi as a “gamechanger” and said it would extend the lives of sufferers, who rarely live beyond their 40s.


Subscribe from just €1 for the first month!


What's Included

With any subscription you will have access to

  • 971569B3-2C5E-4C45-B798-CEADE16987A8

    Unlimited multi-device access to our iPad, iPhone and Android Apps

  • 099C8662-C57C-42F2-9426-F2F90DF17C8F

    Unlimited access to our eReader library

  • 198AE43B-B9CF-4892-8769-D63C2104BA08

    Exclusive daily insight and opinion seven days a week

  • D8F37B78-25E4-4E4A-A376-4F5789B1564A

    Create alerts to never miss a subject that matters to you

  • B15F2521-37CD-4E02-B898-730A20D39F7F

    Get access to exclusive offers for subscribers on gifts and experiences

  • A564FE02-1AB8-4579-AF9D-BA32A2E5ACA7

    Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine

Share this post

Related Stories

Children from poorer families at a disadvantage in education and health, research shows

Tony O’Brien: Draft contract adds to bad blood between Department of Health and consultants

Health Tony O'Brien 3 days ago

Multi-annual health budget mooted to tackle waiting lists

Health Daniel Murray 1 week ago

HSE procurement targets in doubt as Beaumont reports €14m non-compliant spend

Health Donal MacNamee 1 week ago